Skip to main content
. 2023 Mar 24;2(3):100094. doi: 10.1016/j.focus.2023.100094

Table 1.

Characteristics of the Study Population

Characteristics Vaccinated
n=2,632,906
Vaccinated
n=3,238,532
Total
N=5,871,438
p-Value
Age, years, mean (SD) 57.7 (18.0) 66.3 (14.4) 62.4 (16.7) <0.0001
Age group (%) <0.0001
 <45 29.7 10.6 19.1
 45–54 14.6 10.3 12.2
 55–64 16.8 18.5 17.8
 65–74 22.7 36.7 30.4
 ≥75 16.2 23.9 20.5
Sex, n (%) <0.0001
 Female 279,943 (10.6) 269,247 (8.3) 549,190 (9.4)
 Male 2,352,958 (89.4) 2,969,285 (91.7) 5,322,243 (90.6)
Race and ethnicity (%)
 White 66.9 66.7 66.8
 Black 16.1 18.2 17.2
 Hispanic 6.6 7.0 6.9
 Asian/Pacific Islander 1.7 2.0 1.9
 American Indian/Alaskan Native 0.8 0.6 0.7
 Mixed 0.9 0.8 0.8
 Other (missing, declined answer, unknown to patient) 7.0 4.7 5.7
Urban versus rural (%) <0.0001
 Urban 62.8 68.0 65.7
 Rural 35.7 30.9 33.0
 Highly rural 1.5 1.1 1.3
 Previous influenza vaccination (2019–2020 season), n (%) 30.0 62.0 47.9 <0.0001
 Charlson Comorbidity Index, median (IQR) 0 [0–1] 1 [0–2] 0 [0–1] <0.0001
Charlson Comorbidity Index (%) <0.0001
 0 67.2 46.8 56.0
 1 16.1 22.0 19.4
 2 6.8 11.2 9.2
 ≥3 9.9 20.0 15.4
Geographic region <0.0001
 North Atlantic 21.0 22.5 21.8
 Midwest 20.8 20.9 20.9
 Southwest 20.6 21.2 20.9
 Pacific 17.6 18.4 18.1
 Continental 20.0 17.0 18.3
Service connectedness
 None 36.1 36.2 36.2
 <50% 23.2 22.6 22.9
 ≥50% 40.7 41.2 40.9